Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Depreciation and Depletion: 2012-2019

Historic Depreciation and Depletion for Rocket Pharmaceuticals (RCKT) over the last 6 years, with Dec 2019 value amounting to $426,000.

  • Rocket Pharmaceuticals' Depreciation and Depletion rose 9.09% to $1.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $4.6 million, marking a year-over-year increase of 26.40%. This contributed to the annual value of $426,000 for FY2019, which is 29.09% up from last year.
  • As of FY2019, Rocket Pharmaceuticals' Depreciation and Depletion stood at $426,000, which was up 29.09% from $330,000 recorded in FY2018.
  • In the past 5 years, Rocket Pharmaceuticals' Depreciation and Depletion ranged from a high of $426,000 in FY2019 and a low of $45,000 during FY2015.
  • Its 3-year average for Depreciation and Depletion is $320,000, with a median of $330,000 in 2018.
  • Data for Rocket Pharmaceuticals' Depreciation and Depletion shows a peak YoY surged of 204.48% (in 2017) over the last 5 years.
  • Over the past 5 years, Rocket Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $45,000 in 2015, then surged by 48.89% to $67,000 in 2016, then surged by 204.48% to $204,000 in 2017, then soared by 61.76% to $330,000 in 2018, then grew by 29.09% to $426,000 in 2019.